Who is sponsoring NCT04672668?

NCT04672668 is sponsored by Sheba Medical Center.

What drugs are being tested in NCT04672668?

Interventions in NCT04672668: duplex ultrasound for the common femoral artery.

What condition does NCT04672668 study?

NCT04672668 studies Wound Heal, Duplex Volume Flow.

Is NCT04672668 still recruiting?

NCT04672668 is currently status unknown. Last updated 17 December 2020.

Last reviewed 2020-12-17 · How we verify

NCT04672668

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Correlation Between the Volume Flow of the CFA After Angioplasty of Critical Ischemic Limb and Wound Healing

Status unknown Last updated 17 December 2020

What this trial tests

trial testing duplex ultrasound for the common femoral artery in Wound Heal, Duplex Volume Flow in 200 participants. Status unknown.

Timeline

13 December 2020

Primary endpoint
30 December 2021

20 February 2024

Quick facts

Lead sponsor	Sheba Medical Center
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	13 December 2020
Primary completion	30 December 2021
Estimated completion	20 February 2024
Sites	1 location across Israel

Drugs / interventions tested

duplex ultrasound for the common femoral artery

Conditions studied

Wound Heal, Duplex Volume Flow — all drugs for Wound Heal, Duplex Volume Flow →

Sponsor

Sheba Medical Center

Who can join

Adults 12 to 120, any sex, with Wound Heal, Duplex Volume Flow. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

in our study we are examining the volume flow of the common femoral artery before and after angigraphy of a critical ischemic limb, as a predictor for wound healing after the treatment

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sheba Medical Center trials

Trials by the same sponsor.

NCT07401524 — Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage · Phase 4 · not yet recruiting
NCT07523373 — Facial Nerve Monitoring During Parotid and Facial Surgery Using a Non-Invasive Patch · NA · not yet recruiting
NCT07509229 — 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients · Phase 1, PHASE2 · not yet recruiting
NCT07405723 — Arm Position and Blood Pressure Measurement Accuracy During Pregnancy · NA · recruiting
NCT07474987 — Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04672668 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sheba Medical Center
Last refreshed: 17 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04672668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing